Technological watch

Molecular Fusion Technology Permanently Embeds Antimicrobials in Polymer Substrates

A new proprietary line of polymer fusion products with antimicrobial blocking agents has been introduced by Polyfuze Graphics Corp. The products are designed to exceed the rigid labeling standards of the medical, food service, reusable packaging, and health services industries. The labeling technology for olefins developed by the Clarkdale, AZ–based company relies on pigmented polymers to create permanently fused labels for products in the medical, food packaging, outdoor sports and automotive sectors.

Polyfuze fusion technology has unique applicability across all olefin thermoplastic polymer materials where safety, health, and warning labels are required, said the company. Polyfuze’s unique molecular fusion technology permanently unites antimicrobial additives with polymer substrates in critical products such as sharps and biohazardous waste containers, medical beds, medical carts, and hospital laundry carts.

Marty Mares, CEO of Polyfuze parent company Mold In Graph Systems (MIGS), explained that the fusion technology eliminates the sanitary and quality issues of other labeling methods that use surface applications where label edges, layers and adhesives create shelters where microorganisms can thrive and grow despite cleaning with sprays and cleaners.

By integrating proprietary olefinic polymer antimicrobial agents in its molecular fusion technology, Polyfuze Graphics helps manufacturers create “label-free” products that are easy to clean and disinfect. “Ingenuity is one of the great components of America,” said Matthew Stevenson, Polyfuze President and CEO. “Taking established technology and adding key components of another can create great opportunity. The cost of healthcare-associated infections ranges between $28 billion to $45 billion every year. By preventing just one with the combination of these technologies, Polyfuze can offer its contribution to the protection of human life and help reduce the costs associated with these infections.”

Image: Peshkova/Adobe Stock

Publication date: 06/04/2020

Plastics Today


This project has received funding from the Bio Based Industries Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme under grant agreement No 837761.